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Summary
The envelope of Gram-negative bacteria is composed
of two distinct lipid membranes: an inner membrane
and outer membrane. The outer membrane is an
asymmetric bilayer with an inner leaflet of phospholipids and an outer leaflet of lipopolysaccharide. Most
of the steps of lipid synthesis occur within the cytoplasmic compartment of the cell. Lipids must then be
transported across the inner membrane and delivered
to the outer membrane. These topological features
combined with the ability to apply the tools of biochemistry and genetics make the Gram-negative
envelope a fascinating model for the study of lipid
trafficking. In addition, as lipopolysaccharide is
essential for growth of most strains and is a potent
inducer of the mammalian innate immune response
via activation of Toll-like receptors, Gram-negative
lipid transport is also a promising target for the development of novel antibacterial and anti-inflammatory
compounds. This review focuses on recent developments in our understanding of lipid transport across
the inner membrane and to the outer membrane of
Gram-negative bacteria.
Introduction
The envelope of Escherichia coli and other Gram-negative
bacteria contains two distinct lipid bilayers that are separated by the peptidoglycan-containing periplasmic space.
These are the inner membrane (IM) and the outer membrane (OM) (Duong et al., 1997; Raetz and Whitfield,
2002). This envelope is unique to Gram-negative bacteria
and is the site of action of several classes of antibiotics.
In addition, it provides a fascinating model of complex
macromolecular assembly that has been explored using
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the tools of biochemistry, genetics and structural biology.
In spite of this, many molecular details of the assembly of
this structure remain obscure. This review will summarize
recent developments in our understanding of the biogenesis of the Gram-negative cell envelope with special
emphasis on mechanisms of lipid transport to the OM
(Fig. 1).
The Gram-negative IM is composed of (glycerol-phosphate based) phospholipids in both its inner and outer
leaflets as well as integral and peripheral membrane proteins. The IM carries out a variety of functions typically
assigned to both the plasma membrane and specific
organelles in higher organisms. These include protein
export, solute import, cell signalling, biosynthesis, electron transport, and maintenance of a proton motive force
and ATP synthesis.
The OM plays an important role in nutrient uptake but
in addition provides the organism with a remarkable
permeability barrier, conferring resistance to a variety of
detergents and antibiotics. The OM is a unique asymmetric lipid bilayer consisting of an inner face of phospholipids
and an outer face of lipopolysaccharide (LPS). LPS is a
complex, glucosamine-based glycolipid unique to Gramnegative bacteria that is required for viability of most
strains (Raetz and Whitfield, 2002) (Fig. 2). The hydrophobic anchor of LPS is termed lipid A, also known as endotoxin. Lipid A is a powerful activator of the mammalian
innate immune response via its activation of Toll-like
receptors (Poltorak et al., 1998; Beutler, 2004). Lipid A
released by bacterial growth or death during infection can
result in overactivation of these receptors causing monocytes and macrophages to release a number of proinflammatory cytokines leading, if untreated, to a condition
termed Gram-negative septic shock (Riedemann et al.,
2003). In addition to LPS, many enteric bacteria also have
capsular polysaccharide, glycolipids containing phospholipid membrane anchors, present at the outer surface of
the OM.
In addition to phospholipids and LPS, the Gram-negative OM also contains a unique set of transmembrane
proteins that adopt a β-barrel architecture. This protein
structure is not found in IM proteins but is found in the
OM of the eukaryotic mitochondria and chloroplast (Wim-
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Fig. 1. Schematic showing steps of lipid movement through the envelope of E. coli. Phospholipids and Ra-lipid A are synthesized in the cytoplasm
and at the inner leaflet of the IM using cytoplasmic enzymes and precursors. These molecules are then transported across the IM to achieve a
periplasmic orientation. IM protein MsbA plays a major role in this process. MsbA is a homodimer of monomers containing a membrane domain
(shown in green), a linker region, and an ATP binding domain (shown in brown). Some strains add O-antigen to Ra-LPS in the periplasm. LPS
and a portion of the phospholipids must then be moved across the periplasm to reach the OM by yet unknown mechanisms. LPS is then oriented
to the outer leaflet of the OM by a process that may involve the protein Imp/OstA (blue). Arrows refer to unidirectional or bidirectional transport
of lipids.

ley, 2003). Many OM proteins carry out functions in nutrient transport into the cell; but some function in protein
secretion, adhesion or catalysis. The only non-β-barrel
proteins found in the E. coli OM are the lipoproteins that
associate with the membrane via an N-terminal lipid
modification (Tokuda and Matsuyama, 2004). OM proteins are synthesized at the cytoplasmic protein synthesis machinery, and then transported across the IM,
before being incorporated into the OM. The export of OM
proteins requires the IM Sec preprotein translocation
apparatus and periplasmic folding factors such as SurA.
Recent evidence has indicated that the OM protein
Omp85/YaeT is required for proper export and oligomerization of OM proteins (Voulhoux et al., 2003). Export
and folding of OM proteins has been reviewed in marvellous detail elsewhere (Wickner et al., 1991; Mori and Ito,
2001; Silhavy et al., 2006) and is not considered extensively here except to point out that extracytoplasmic
assembly of both proteins and lipids are required for
proper function of the Gram-negative OM.

Membrane lipids and biosynthesis
The major membrane lipids of E. coli include LPS and the
phospholipids phosphatidylethanolamine (PE) (Fig. 2),
phosphatidylglycerol (PG) and cardiolipin. As mentioned
above, phospholipids are found in both the IM and the OM.
In contrast, essentially all of the LPS is found in the outer
leaflet of the OM. The inner leaflet of the IM is the site of
the late steps in the synthesis of phospholipids and LPS.
Indeed, E. coli K-12, which produces an LPS without an
attached O-antigen, synthesizes the entire LPS molecule
in the interior of the cell (Fig. 1). This topology is inferred
from both the predicted cytoplasmic location of enzyme
active sites and of enzyme substrates (ATP, nucleotide
sugars, acyl-ACPs, etc.).
The biosynthesis of phospholipids occurs via the
Kennedy pathway (Cronan, 2003) and the biosynthesis of
lipid A occurs via the Raetz pathway (Raetz and Whitfield,
2002). The structural genes for the enzymes involved in
these pathways have been identified and characterized in
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Fig. 2. A. Structures of the major E. coli membrane lipids PE and Kdo2-lipid A.
B. Representative structure of E. coli LPS with core sugars shown. Phosphates are shown as red circles, ethanolamine by the curved line with
an amine group, and sugars by hexagons. For simplicity, detailed information on linkages between sugars is not shown.

detail and in at least two cases (the fatty acid synthesis
pathway and the LpxC deacetylase of the lipid A pathway)
are promising targets for the development of novel antibacterial compounds (Onishi et al., 1996; Heath and
Rock, 2004; McClerren et al., 2005). Ra-lipid A is the LPS
found in common laboratory E. coli K12 strains and contains core oligosaccharide sugars covalently attached to
lipid A (Fig. 2). LPS from many natural isolates additionally contains an O-antigen polymer ligated to the core
region of LPS. Ra-lipid A is synthesized at the inner leaflet
of the IM with the sugars donated by nucleotide-sugar
precursors, while the O-antigen pentasaccharide repeat
is added in the periplasm from an undecaprenol-pyrophosphate precursor (Raetz and Whitfield, 2002).
First step: across the IM. Model systems
Once the cytoplasmic steps of biosynthesis are complete,
newly synthesized phospholipids and Ra-lipid A are transported across the IM bilayer. The mechanisms used to
shuttle lipids across biological membranes (flip-flop)
remain poorly understood. Transport of amphipathic lipids

across a hydrophobic lipid bilayer is predicted to be thermodynamically unfavourable, requiring input of energy
(Singer and Nicolson, 1972). Transport of lipids across
bilayers has been studied in many excellent in vitro models. In this discussion, I will use the general term flip-flop
to describe the outward movement of lipids across a
bilayer. While this term does not discern outward from
inward movement of lipids, only the former will be considered. Lipid flip-flop in model lipid bilayers is extremely
slow, with half-lives on the order of hours to days, but is
very fast in biological membranes, occurring in seconds
to tens of seconds (Rothman and Kennedy, 1977). This
has led to the conclusion that lipid flip-flop in biological
membranes is protein catalysed. Several candidate proteins have been identified in eukaryotes that catalyse
transbilayer movement of different classes of lipids
(Daleke, 2003; Holthuis and Levine, 2005; Pohl et al.,
2005). However, in prokaryotes, the only protein thus far
identified with a proven role in lipid transport is MsbA (see
below).
Differing conclusions have been reached with regard to
energy requirements for IM lipid transport. In some sys-
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tems, lipid flip-flop is ATP dependent but not in others.
Work by deKruijff and colleagues suggests that lipid flipflop in reconstituted vesicles is energy independent and
requires only hydrophobic membrane-spanning α-helical
peptides (Kol et al., 2004). In their studies, the authors
tested the ability of membrane-spanning peptides to
induce flip-flop of short chained, fluorescently labelled
phospholipids (C6-NBD-PE and C6-NBD-PG) in artificial
bilayers (Kol et al., 2001). They found that vesicles containing the model transmembrane α-helical peptide
GKKL(AL)12KKA supported flip-flop of the short-chain lipids, whereas flip-flop was negligible in lipid vesicles alone.
This work represents an interesting alternative to the concept that a dedicated protein machinery catalyses transbilayer lipid movement and that suggests this activity may
be a general property of membrane proteins containing
α-helical membrane-spanning domains.
Menon and colleagues have presented evidence for an
ATP-independent flippase activity in membranes of Grampositive bacteria (Hrafnsdottir and Menon, 2000) and this
activity has also been detected in membranes from Gramnegative bacteria (Kubelt et al., 2002). Using di-C4-phosphatidylcholine as a substrate for the flippase assay, it was
possible to solubilize, reconstitute and partially purify the
activity. However, to date, a protein(s) has not been identified nor has a mechanism been established.
On the other hand, work with reconstituted ATP binding
cassette (ABC) transporters from bacteria (Margolles
et al., 1999) or humans (Romsicki and Sharom, 2001) has
shown that they possess ATP-dependent phospholipid
flippase activity in vitro. ABC transporter proteins use the
energy of ATP hydrolysis to transport a variety of lipid and
non-lipid substrates across membranes, and are present
in all three domains of living organisms. Konings and
colleagues have demonstrated (again using short-chain
fluorescent phospholipid analogues) that purified, reconstituted LmrA, an ABC transporter from Lactococcus lactis, possesses phospholipid flippase activity in vitro that is
dependent on exogenous ATP (Margolles et al., 1999). In
a similar manner, reconstituted human p-glycoprotein/
MDR1 (ABCB1) has been shown to possess ATP-dependent flippase activity with a wide variety of long- and shortchain phospholipid analogues (Romsicki and Sharom,
2001). While in vitro studies of phospholipid flip-flop activity have proven informative, caution should be used when
extrapolating from these results to the in vivo situation, as
they typically employ short-chain, water-soluble lipid analogues or contain other modifications that create structurally unique molecules that may differ in important ways
from their naturally occurring counterparts.
In vivo studies and MsbA, a putative flippase
A large amount of genetic, structural and biochemical

evidence implicates MsbA in IM transport of newly synthesized Ra-lipid A and probably phospholipids (Zhou
et al., 1998; Doerrler et al., 2001; 2004; Reyes and
Chang, 2005). MsbA was first identified by its ability to
complement, when present in multiple copies, the growth
defect of an htrB deletion mutant at elevated temperatures
(Karow and Georgopoulos, 1993). HtrB is an acyltransferase involved in a late step of lipid A biosynthesis (Clementz et al., 1996) and mutants, though viable up to 33°C
(Karow et al., 1991), produce underacylated LPS that is
not transported efficiently to the OM at high growth rates
(Zhou et al., 1998). MsbA is an essential IM protein, with
mutations being lethal to most Gram-negative, and a
member of the ABC transporter superfamily of proteins
(Karow and Georgopoulos, 1993). MsbA homologues are
found in nearly all species and include p-glycoprotein/
MDR1 (ABCB1), a protein overexpressed in human carcinoma cells, and a contributor to the multidrug-resistance
phenotype observed in many cancer cell lines. A role for
MDR proteins, and other ABC transporters, in lipid trafficking in eukaryotes is well established (Pohl et al., 2005).
Most notably, an MDR2 knockout mouse has a defect in
phospholipid secretion into bile (Smit et al., 1993). Several
MsbA crystal structures have been published and all suggest that the protein forms a homodimer in the IM with a
chamber oriented towards the cytoplasm capable of
accommodating lipid molecules (see below) (Chang and
Roth, 2001; Chang, 2003; Reyes and Chang, 2005).
Indeed, MsbA has served as a useful model providing
structural insights into the mechanisms of action of other
ABC transporters (Conseil et al., 2006).
A temperature sensitive E. coli mutant strain (WD2)
containing a single amino acid substitution (A270T) in one
of the membrane-spanning helices of MsbA was isolated
and characterized (Doerrler et al., 2001). Upon inactivation of MsbA by a shift to the non-permissive growth
temperature of 42–44°C, the mutant rapidly (within
30 min) accumulates newly synthesized LPS and phospholipids in the IM. This is accompanied by the formation
of IM folds and invaginations visible by electron microscopy. Subsequent studies localized the accumulating lipids to the cytoplasmic leaflet of the IM (Doerrler et al.,
2004). Topological analysis of lipids in a living cell is technically difficult and was done using different approaches
for phospholipids and LPS. Membrane impermeable
reagents that covalently modify the amine moiety of PE
were less reactive with newly synthesized PE following
inactivation of MsbA, indicating inaccessibility to these
reagents and a cytoplasmic orientation. For analysis of
the topology of newly synthesized lipid A, a strain was
constructed that expresses the temperature-sensitive
msbA allele in a polymyxin-resistant background
(WD102). Polymyxin-resistant strains of E. coli and Salmonella covalently modify lipid A with cationic substituents
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4-amino-4-deoxy-L-arabinose and phosphoethanolamine
(Zhou et al., 1999; Trent et al., 2001). Both of these modifications are required for resistance to the antibiotic
polymyxin (Lee et al., 2004; Breazeale et al., 2005).
Importantly, the nature of the enzymes and substrates
involved in these modifications strongly suggests that lipid
A modification occurs in the periplasm, following IM flipflop. Following inactivation of MsbA in WD102, newly synthesized lipid A was located in the IM and entirely unmodified with the cationic substituents, indicating that the lipid
had not accessed the periplasmic compartment. This
result strongly suggests that the newly synthesized LPS
in this strain is oriented towards the cytoplasm. In these
studies, the combined use of genetics and biochemistry
has provided strong evidence that MsbA is required for
transport of both LPS and phospholipids across the IM of
E. coli.
To date, no in vitro system has been described to study
the transbilayer movement of lipid A or any lipid A-like
analogue. Purified hexaacylated lipid A, Kdo2-lipid A and
LPS have a stimulatory effect on the ATPase activity of
the purified and reconstituted MsbA protein (Doerrler and
Raetz, 2002), perhaps indicative of recognition and transport by the protein. Stimulation of this ATPase activity was
only observed with hexaacylated lipid A species, and not
with other LPS precursors such as tetraacylated lipid IVA
or diacylated lipid X.
It is important to stress at this point that, in spite of the
above in vivo evidence, and in vitro evidence that purified
and reconstituted MsbA exhibits a lipid-stimulated ATPase
activity (Doerrler and Raetz, 2002), MsbA has never been
shown to possess phospholipid (or lipid A) flip-flop activity
in vitro. In fact, one study has reported that purified and
reconstituted MsbA is not capable of promoting flip-flop
of short-chain phospholipids in an ATP-dependent or
-independent manner under conditions where membranespanning peptides were active (Kol et al., 2003). In addition, integral IM proteins leader peptidase and the potassium channel KcsA were able to induce lipid flip-flop,
presumably due to the presence of membrane-spanning
domains. Ironically, MsbA, a membrane protein containing
six membrane-spanning helices in each monomer, was
inactive in the same assay.
Furthermore, the msbA gene has been deleted from a
capsule-deficient strain of Neisseria meningitidis (Tefsen
et al., 2005a), an organism that does not require LPS for
viability (Steeghs et al., 1998). The msbA deletion mutant
is viable with only a slight growth defect and produces only
small amounts of LPS but greatly increases amounts of
phospholipids. Importantly, the mutant appears to produce
an OM, as demonstrated by electron microscopy, which
presumably consists mainly of phospholipids (though not
directly shown by the authors due to technical problems
separating IM and OM from the organism). The evidence

from these two studies seems to suggest that MsbA is
involved in LPS transport but not required for phospholipid
transport across the IM.
How do we resolve this paradox? On the one hand,
msbA conditional mutants convincingly accumulate phospholipids and LPS on the inner surface of the IM upon
shift to non-permissive conditions (Doerrler et al., 2001;
2004). On the other hand, in vitro studies thus far are not
consistent with a phospholipid flippase activity by the protein (Kol et al., 2003) and in N. meningitidis loss of MsbA
does not appear to affect phospholipid transport to the OM
(Tefsen et al., 2005a). One interpretation of the in vitro
study failing to demonstrate an MsbA flippase activity is
that additional undiscovered proteins in addition to MsbA
may be required for efficient phospholipid transport across
the IM in vivo and these are not present in the reconstituted systems. In bacteria, ABC transporter systems
involved in import and export of substrates often utilize a
soluble periplasmic binding protein component. In other
words, MsbA may be necessary but not sufficient for flipflop of phospholipids. To date, a protein that physically
interacts with MsbA has not been identified. MsbA produced in the Gram-positive organism L. lactis is capable
of conferring drug resistance to the organism (Woebking
et al., 2005), suggesting that this property of the protein
does not require additional host-specific factors. MsbA
overexpression conferred an 86-fold resistance to erythromycin in L. lactis and transport of ethidium bromide and
Hoechst 33342 was observed. Hoechst 33342 is an fluorescent, amphipathic drug transported by several MDR
proteins (Margolles et al., 1999). Importantly, transport of
Hoechst 33342 was inhibited by free lipid A with a Ki of
57 µM, indicating a direct interaction of lipid A with the
protein and underscoring the relevance of the Gram-positive model for the study of drug transport properties of
MsbA.
The results from the N. meningitidis msbA deletion
strain are more difficult to reconcile with the E. coli
mutants. In this organism, perhaps another transport protein or an entirely different mechanism is used to transport
phospholipids across the IM. Details of the molecular
mechanism of MsbA-dependent and -independent lipid
transport in E. coli and other Gram-negative species await
further biochemical and genetic studies.
Another possibility that cannot be discounted is that
MsbA may only be required for the IM flip-flop of Ra-lipid
A but not phospholipids. Phospholipids do accumulate in
the IM of the MsbA conditional mutant WD2 at the nonpermissive temperature (Doerrler et al., 2001; 2004).
However, it is a formal possibility that this accumulation
may be a secondary effect of a toxic accumulation of Ralipid A in the cytoplasm and phospholipids are not normally transported directly by the protein. Bioinformatic
studies support this hypothesis. MsbA is only found in
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Gram-negative bacteria that synthesize lipid A. The best
MsbA homologues from Gram-positive bacteria, such as
LmrA, have no greater identity to MsbA than the MDR
proteins of mammalian species (roughly 30–35%), some
of which may be involved in phospholipid transport. This
is true even of Deinococcus radiodurans and the spirochaetes Borrelia burgdorferi and Treponema pallidum,
organisms that possess OM but do not make lipid A.
MsbA: structural studies
Recent structural studies have shed light upon possible
mechanisms of MsbA function. I will briefly describe some
recent findings in this exciting field and direct readers to
more detailed reviews for further information (Davidson
and Chen, 2005). The recently reported structure of Salmonella typhimurium MsbA by Chang’s group (Reyes and
Chang, 2005) is regarded as a great improvement over
the first two reported structures by the group (E. coli and
Vibrio cholera respectively) (Chang and Roth, 2001;
Chang, 2003) that were criticized as non-physiologic due
to missing or misfolded nucleotide binding domains. All
structures represent MsbA as a homodimer with six transmembrane helices in each monomer, a linker region and
a cytoplasmic nucleotide-binding domain containing the

A

highly conserved Walker motifs. The newest structure
shows the NBD correctly folded in the post-hydrolysis
state with bound ADP-vanadate (Fig. 3). In addition, RaLPS was included during the formation of crystals and is
found bound to the protein on the periplasmic side of the
membrane domain in a, presumably, ‘post-flipped’ conformation. These structures support the concept that MsbA
is an ATP-powered ‘pump’ and sheds light upon the mechanism of action of other members of the MDR family of
proteins.
The MsbA temperature-sensitive mutant WD2 contains
the single amino acid substitution A270T (Doerrler et al.,
2001). Analysis of the location of the A270 residue in the
newly published crystal structure of S. typhimurium MsbA
(91% sequence identity to E. coli MsbA) shows that it lies
at the dimer interface near the adjacent A270 residue
(Fig. 3) at the periplasmic surface of the protein. The sidechain carbons of the two alanine residues are effectively
in contact, only 3.28 Å apart. Threonines at this site, with
its bulkier side-chain, may effectively destabilize the dimer
at elevated temperatures and explain the temperaturesensitive nature of this mutation.
Electron paramagnetic resonance (EPR) was utilized to
illustrate the dynamic nature of the MsbA power stroke
(Dong et al., 2005). In a heroic effort, the authors began
Fig. 3. Crystal structure of S. typhimurium
MsbA highlighting the location of alanine 270,
which is mutated to threonine in the MsbA temperature-sensitive mutant WD2 (Doerrler et al.,
2001). Analysis of the location of the A270 residue in the newly published crystal structure of
S. typhimurium MsbA (91% identity to E. coli
MsbA) (Reyes and Chang, 2005) shows that it
lies at the dimer interface near the adjacent
A270 residue at the periplasmic surface of the
protein (yellow amino acid). The side-chain carbons of the alanine residues are effectively in
contact, only 3.28 Å apart. A threonine at this
site with its bulkier side-chain may destabilize
the dimer at elevated temperatures and explain
the temperature sensitive nature of this
mutation.
A and B. View of dimer in the plane of the
membrane.
C. View of MsbA dimer perpendicular to membrane from periplasmic surface.
D. Close-up of A270 residues showing distance
between side-chain carbons. Co-ordinates
were obtained from the RCSB Protein Data
Bank (Berman et al., 2000).
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with a cysteine-less MsbA mutant and individually introduced engineered cysteine residues. More than 100 different mutants were produced containing single cysteines
at different locations. The individual proteins were then
expressed and purified, reconstituted into lipid bilayers,
and labelled with spin label probes. Using site-directed
spin labelling and EPR, it was possible to determine if an
individual amino acid is buried within the protein, exposed
to an aqueous environment, or exposed to the lipid bilayer.
The authors demonstrated marked changes in conformation upon addition of ATP. Additionally, they confirmed
many aspects of the crystal structures but, interestingly,
their work shows that the periplasmic loops of MsbA are
much more open to the aqueous environment than the
crystal structures suggest. The approach has the advantage over crystallography that it is possible to study the
protein reconstituted in its natural bilayer environment.
The only criticism of this work is that while the mutant
proteins were tested for ATPase activity (and some only
had only 10% of wild type activity), none were tested for
in vivo function by their ability to complement an msbA
chromosomal deletion.
Across the great divide: the periplasm
Following transport across the IM, proteins and lipids must
move to the OM and, in the case of LPS, to the outer
leaflet of the OM (Fig. 1). The mechanisms by which
nascent proteins, phospholipids and LPS are moved
across the periplasm and are assembled into the OM
remain poorly characterized. However, there do appear to
be different requirements for movement of LPS and phospholipids. In the 1970s, Osborn and colleagues demonstrated that phospholipids were capable of moving back
and forth between IM and OM of Salmonella (double
arrow in Fig. 1) (Jones and Osborn, 1977). LPS did not
show such behaviour in these experiments.
More recently, de Cock and colleagues reported an in
vitro system for studying transport of newly synthesized
phospholipids and LPS from spheroplasts to the OM (Tefsen et al., 2005b). They reported that transport of newly
synthesized LPS to the OM was dependent only upon a
functional copy of MsbA, and no soluble periplasmic components were required. In contrast, newly synthesized
phospholipids were not transported to the OM of spheroplasts, indicating that a soluble periplasmic intermediate
may be required for this step. It was speculated that LPS
might be transported to the OM via points of contact
between the IM and OM. The molecular nature of these
points of contact is currently unknown but this observation
is reminiscent of the Bayer’s bridges first observed by
electron microscopy in the 1960s (Bayer, 1968). These
EM data suggest that points of physical contact may exist
between the IM and OM in the periplasmic space that

could be used for transport of molecules between the
membranes. Amazingly, newly synthesized LPS was
reported to appear in patches in the OM that were adjacent to zones of adhesion between the two membranes
(Muhlradt et al., 1973). The existence of these membrane
contacts was called into question by Kellenberger using
improved cryofixation techniques and it is not clear if they
represent actual physical structures or are artifacts of the
cell fixation process used in electron microscopy (Kellenberger, 1990; Bayer, 1991). At any rate, the in vitro system
and fascinating results reported by de Cock and colleagues (Tefsen et al., 2005b) allow for the first time a
biochemical approach to study the movement of phospholipids across the periplasm.
Delivery of LPS to the outer surface of the OM
Incorporation into the inner leaflet of the OM presumably
completes the journey for OM phospholipids. Once these
molecules are assembled into the inner leaflet of the OM,
they can only be transported back and forth between the
IM and OM, as reported by Osborn and colleagues (Jones
and Osborn, 1977), or diffuse laterally in the inner leaflet
of the OM (Fig. 1). Agents that disrupt the OM, such as
the calcium chelator EDTA, drive phospholipids to the
outer leaflet of the OM where they can become substrates
for the OM lipid A acyltransferase PagP (Jia et al., 2004),
which plays a role in pathogenesis and resistance to antimicrobial peptides (Bishop, 2005).
In contrast to phospholipids, LPS needs to be flipped
across the OM in a process analogous to IM LPS flip-flop
carried out by MsbA. However, no obvious energy source
is available to drive this process in the periplasm. Recent
publications have identified two OM proteins potentially
involved in lipid transport to the OM, YaeT (or Omp85) and
Imp (OstA). E. coli YaeT is encoded by an essential gene
located near minute 4 of the chromosome just upstream
of genes involved in LPS and phospholipid biosynthesis.
Depletion of Omp85 from N. meningitidis has been
reported to result in loss of lipid targeting to the OM
(Genevrois et al., 2003). However, this result has been
disputed by other groups that have shown that depletion
of Omp85/YaeT results in a loss of OM protein targeting
and oligomerization (Voulhoux et al., 2003; Doerrler and
Raetz, 2005; Werner and Misra, 2005) but has minimal
effects on lipid transport (Doerrler and Raetz, 2005). YaeT
is present in essentially all Gram-negative genomes
sequenced to date including those organisms that do not
synthesize LPS such as D. radiodurans and the spirochaetes B. burgdorferi and T. pallidum, consistent with a role
in protein targeting to the OM. In addition, YaeT has
sequence similarity to Toc75 and Sam50 involved in protein import into the chloroplast and mitochondria respectively, suggesting that aspects of OM assembly are
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conserved across evolution (Gentle et al., 2005; Schleiff
and Soll, 2005).
The only other protein currently suspected to play a role
in LPS targeting to the OM is Imp/OstA (increased membrane permeability/organic solvent tolerance) or simply
Imp. However, the evidence for a role of Imp in this process is indirect. Imp was first identified as a protein
required for organic solvent tolerance (Sampson et al.,
1989; Aono et al., 1994). Silhavy and colleagues demonstrated that imp encodes an essential OM protein in E. coli
and that depletion of the protein results in abnormalities
in OM assembly (Braun and Silhavy, 2002). Interestingly,
depletion of Imp results in increased density of OM during
sucrose gradient centrifugation, consistent with loss of
lipid incorporation. More recently, Tommassen and colleagues have presented striking evidence that Imp is
required for proper transport of LPS to the cell surface of
N. meningitidis (Bos et al., 2004). This conclusion was
based upon loss of surface accessibility of LPS to
neuraminidase and loss of lipid A modification by the OM
deacylase PagL. However, it was not possible to separate
the IM from OM in this organism using sucrose gradients.
Therefore, it is not possible to determine exactly where
the LPS accumulates, information needed to assign a
role to the protein in lipid trafficking. Interestingly, imp
and msbA (see above), as well as the genes involved
in LPS biosynthesis, are all nonessential genes in
N. meningitidis. This is in contrast to E. coli and all other
Gram-negative strains tested to date. The first gene of
lipid A biosynthesis, lpxA, can be deleted from
N. meningitidis, thereby blocking LPS synthesis but not
affecting viability (Steeghs et al., 2001). The OM protein
profile was unaltered from wild type in the lpxA mutant
strain. It is thought that phospholipids can functionally
replace LPS in these strains. These results suggest
marked differences in envelope biology exist between
species of Gram-negative bacteria.
More recently, the laboratories of Silhavy and Kahne
found, applying chemistry and genetics in a technique
termed ‘chemical conditionality’, that strains containing
loss of function alleles of the gene yfgL in addition to an
imp mutation (containing a 23-codon deletion) were
resistant to certain antibiotic compounds to which the
imp mutant itself was hypersensitive (Ruiz et al., 2005).
YfgL was in turn found to be an OM lipoprotein associated with a heterooligomeric OM complex containing
YaeT and two other lipoproteins (but not Imp) (Wu et al.,
2005; Silhavy et al., 2006). While these studies shed
light on OM biogenesis with regard to protein trafficking,
the role of these proteins in lipid trafficking was not
addressed. The exact mechanism of transport of LPS
across the OM remains to be established but the aforementioned studies clearly suggest an important role for
Imp in this process.

Outlook
Much remains to be learned about the process of lipid
movement through the Gram-negative cell envelope and
several controversies remain to be settled. First, what is
the true role of MsbA? While it is implicated in transmembrane movement of both LPS and phospholipids, in vitro
systems and the N. meningitidis msbA knockout seem to
suggest differing mechanisms for the transport of these
two classes of molecules across the IM. Second, what are
the energy requirements for transport across the IM? The
involvement of the ABC transporter MsbA suggests that
ATP is required. However, past studies have reported that
disruption of the proton motive force under conditions that
do not deplete ATP synthesis inhibits lipid A-core transport
to the OM (McGrath and Osborn, 1991). Other studies
have concluded that energy is not required for phospholipid transport across the IM, which needs only membrane-spanning helices of integral membrane proteins
(Kol et al., 2004). Finally, the molecular requirements and
mechanisms for lipid translocation across the periplasm
and across the OM are all but unknown. What proteins
are required for these processes and what is the role of
Imp in this process?
While no specific inhibitors of the process of lipid export
are known, this pathway represents a potential target for
the development of novel antibiotics. Recall that MsbA has
extensive sequence identity to mammalian p-glycoprotein/
MDR1. P-glycoprotein was first identified by virtue of its
overexpression in multidrug-resistant cancer cell lines
(Chen et al., 1986; Gros et al., 1986). There is currently
great interest by the pharmaceutical industry in identifying
in vivo inhibitors of p-glycoprotein in order to reduce drug
excretion from multidrug-resistant cancer cells and to
improve treatment options of cancer patients (Ambudkar
et al., 1999). In fact, clinical trials of candidate inhibitors
have been conducted. Lead compounds identified in
these types of screens could represent a starting point in
the search for in vivo modulators of the activity of MsbA
and, indeed, novel classes of antibiotics.
In conclusion, the biogenesis of the Gram-negative
envelope is an intriguing system for the study of lipid
trafficking. These studies have brought into play the
tools of genetics, biochemistry and structural biology.
While we have learned much about this system in the
past few years, many questions remain stubbornly
unanswered.
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